You are here: Industry Insights > SII

News List

SII is legally bound to supply COVID-19 vaccines: COVAX expresspharma
April 12, 2021
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and the rest on option.
India blessed to have a major manufacturer of global vaccines: World Bank President on SII expresspharma
April 07, 2021
Malpass said it is important and vital to have early delivery of vaccines to developing countries because it's going to take a long time to actually do the vaccinations.
DCGI extends shelf life of COVISHIELD: Document, sources expresspharma
April 01, 2021
India’s drug regulator has allowed the AstraZeneca COVID-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters.
SII postpones launch of Novavax vaccine in India expresspharma
March 29, 2021
Poonawalla said earlier this month that a temporary US ban on exports of critical raw materials could limit the production of coronavirus vaccines such as Novavax.
SII gets purchase order from government for 10 crore doses of Covishield expresspharma
March 19, 2021
Serum Institute of India (SII) has received a new purchase order from the Government of India for the supply of 10-crore doses of the Oxford-AstraZeneca COVID-19 vaccine — Covishield — each dose costing Rs 157.5, including GST, according to official ...
SII asks government to intervene over import of COVID-19 vaccine raw material from US expresspharma
March 09, 2021
The company said this would enable it to import essential products soon from the US for uninterrupted manufacturing and supply of COVID-19 vaccines in India and globally.
SII writes letter to PMO recommending reforms in drug regulatory system expresspharma
March 05, 2021
The letter requests that the provision for manufacturing and stockpiling of COVID-19 vaccine under clinical trial for marketing authorisation for sale or distribution should be implemented for non-COVID-19 vaccines as well.
Chinese hackers target Indian vaccine makers SII, Bharat Biotech, says security firm expresspharma
March 03, 2021
North Korean hackers also tried to break into the systems of British drugmaker AstraZeneca.
UK to receive 10 million AstraZeneca Covid vaccine doses from India: Report expresspharma
March 03, 2021
The UK will receive 10 million AstraZeneca COVID-19 vaccine doses made by the Serum Institute of India (SII), the UK government.
Serum Institute of India says prioritising domestic vaccine needs expresspharma
February 22, 2021
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded COVISHIELD.

Previous page 1 2 3 4 5 6 Next page